Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 14,228 | 581 | 18,306 | 6,437 | 7,551 |
| Gross Profit | 14,228 | 581 | 18,306 | 6,437 | 7,551 |
| Operating Expenses | 52,431 | 36,134 | 36,161 | 36,065 | 33,541 |
| Operating Income | -38,203 | -35,553 | -17,855 | -29,628 | -25,990 |
| Other Income | 231 | 462 | -2,104 | -850 | 2,167 |
| Pre-tax Income | -37,972 | -35,091 | -19,959 | -30,478 | -23,823 |
| Income Tax | -553 | -161 | 27 | 119 | -427 |
| Net Income Continuous | -37,419 | -34,930 | -19,986 | -30,597 | -23,396 |
| Net Income | $-37,419 | $-34,930 | $-19,986 | $-30,597 | $-23,396 |
| EPS Basic Total Ops | -0.11 | -0.11 | -0.08 | -0.14 | -0.09 |
| EPS Basic Continuous Ops | -0.11 | -0.11 | -0.08 | -0.14 | -0.09 |
| EPS Diluted Total Ops | -0.11 | -0.11 | -0.08 | -0.14 | -0.08 |
| EPS Diluted Continuous Ops | -0.11 | -0.11 | -0.08 | -0.14 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.11 | -0.08 | -0.14 | -0.11 |
| EBITDA(a) | $-36,320 | $-33,655 | $-15,958 | $-27,704 | $-23,582 |